Phase 1 Study of Role of Botox in Myofascial Temporomandibular Disorder
Latest Information Update: 25 Jan 2018
Price :
$35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Bruxism; Myofascial pain; Temporomandibular joint dysfunction syndrome
- Focus Therapeutic Use
- 21 Jan 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 01 Aug 2014 New trial record